gemini-2.5-flash-lite-preview-09-2025| input-price: 0.1 output-price: 0.4 max-context-length: 128_000 (cost: $0.007) · Anfrage: 2025-10-20T06:23:14.329230

Generated by rs-summarizer Version unbekannt

Abstract

This is the first part of a two-part lecture by Dr. Jared Gardner on Fibroblastic/Histiocytic Lesions and more, presented to the Australasian Dermatopathology Meeting. This segment focuses heavily on the diagnosis and differential diagnosis of Dermatofibroma (DF), contrasting its features with Dermatofibrosarcoma Protuberans (DFSP).

Dr. Gardner details the classic histological features of DF, including spindle cell proliferation, collagen trapping, and epidermal changes (like acanthosis and rete ridging). He emphasizes recognizing benign mimics, such as epidermal induction alongside DF, and notes that features like plump cells, hemosiderin, and fat necrosis argue against DFSP. Specific variants discussed include cellular DF, aneurysmal DF, and lipidized DF. The section on DFSP highlights its characteristic bland, monotonous spindle cells, CD34 positivity (often with a peripheral halo), and characteristic honeycomb fat entrapment, distinguishing it from the reactive changes seen in DF.

The lecture then pivots to address other entities that can mimic DFs or be confused with each other: Fibrous Hamartoma of Infancy (noting its characteristic triad), Myofibroma, Inclusion Body Fibromatosis, Giant Cell Tumor of Tendon Sheath (emphasizing non-giant cell features), and Nodule/Proliferative Fasciitis (highlighting myxoid cystic degeneration). Finally, the discussion expands to other histiocytic-appearing lesions, including Juvenile Xanthogranuloma (JXG), Reticular Histiocytoma, and Langerhans Cell Histiocytosis (LCH), concluding with a detailed case example of an unexpected Mycobacterial Pseudotumor mimicking Rosai-Dorfman disease.


Summary of Transcript: Fibroblastic Lesions (Part 1)

Dermatofibroma (DF) Basics and Histology (0:00:05 – 0:17:00)

Dermatofibrosarcoma Protuberans (DFSP) (0:34:36 – 0:49:37)

Fibrosarcoma and Related Entities (0:43:24 – 0:53:40)

Other Spindle Cell/Histiocytic Tumors (0:55:27 – End)

Summary Rating: No ratings yet
Article Rating: No ratings yet

Source